| Period Ending | Dec 29, 2012 | Sep 29, 2012 | Jul 7, 2012 | Apr 14, 2012 |
|---|
|
Total Revenue
|
240,679
|
213,317
|
223,677
|
299,459
| | Cost of Revenue | 200,959 | 181,762 | 186,078 | 248,852 | | |
Gross Profit
|
39,720
|
31,555
|
37,599
|
50,607
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 26,878 | 24,469 | 25,574 | 33,877 |
|
Non Recurring | 639 | 1,250 | 602 | 983 |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
12,203
|
5,836
|
11,423
|
15,747
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (2,690) |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 9,513 | 5,836 | 11,423 | 15,747 |
|
Interest Expense | 1,469 | 1,093 | 1,267 | 1,833 |
|
Income Before Tax | 8,044 | 4,743 | 10,156 | 13,914 |
|
Income Tax Expense | 1,552 | 1,210 | 2,408 | 3,356 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 6,492 | 3,533 | 7,748 | 10,558 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
6,492
|
3,533
|
7,748
|
10,558
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
6,492
|
3,533
|
7,748
|
10,558
|
|
0.28(0.57%) 12:41PM EDT - Nasdaq Real Time Price